Thrilled to share that my thesis work on #ferroptosis is now live on @biorxivpreprint!. Here in the @YatrikShahLab we show that RSL3 is a non-selective inhibitor of the Selenoproteome, revealing new therapeutic opportunities in #colorectalcancer .

Always great catching up with @JunQiLab! Two @jaybradner lab alums staying excited about science!

You know you’re back in Boston when you pass not one, not two, but three separate Dunkin’ Donuts just on the walk to the Logan Airport baggage claim.

RT @biorxiv_cancer: Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer .

RT @biorxivpreprint: Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer .

Excited to share our review article on the roles of Selenoproteins in Cancer! . These selenocysteine containing proteins are emerging as regulators of oxidative stress and redox regulation in many cancers.@trendscancer @CellCellPress @YatrikShahLab .